Background
The Swiss life science company CUTISS successfully closed its Series B financing round, initially aiming for CHF 20 million but eventually oversubscribing. This significant funding was led by Giammaria Giuliani (Gisev Family Office) and seconded by the Wyss Foundation, along with other new and existing private investors.
Deal Summary
Fundraising
.png)